Characteristics of Toxic Keratopathy, an In Vivo Confocal Microscopy Study.


Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
01 09 2021
Historique:
entrez: 8 9 2021
pubmed: 9 9 2021
medline: 21 10 2021
Statut: ppublish

Résumé

Toxic keratopathy (TK) involves complex clinical manifestations and is difficult to differentiate from other ocular surface diseases by conventional slit-lamp examination. The challenge faced by clinicians in confidently diagnosing TK cannot be underestimated. This study aimed to explore the microstructural characteristics and diagnostic parameters by in vivo confocal microscopy (IVCM) in TK. In this prospective, cross-sectional, comparative study, slit-lamp and IVCM examinations were performed on 20 normal eyes and 54 eyes with TK. Based on slit-lamp imaging, TK subjects were divided into four groups: superficial punctate keratitis (n = 10 eyes), pseudodendritic keratitis (n = 14 eyes), ulcerative keratitis (UK; n = 16 eyes), and ring keratitis (RK; n = 14 eyes). The microstructural characteristics of TK were described according to the following IVCM parameters: basal cell (BC) density, dendritiform cell (DC) density, DC size, corneal nerve fiber (CNF) length, nerve tortuosity, and keratocyte reflectivity. A receiver operating characteristic (ROC) curve model was also formulated to compare the predictive power of BC density, DC density, and CNF length. TK eyes showed significantly higher values for DC density (45.8 cells/mm2; range, 25.0-100.0) compared with normal eyes (24.0 cells/mm2; range, 20.8-32.3; P = 0.013; DC size (111.0 µm2; range, 92.0-137.8) compared with normal eyes (63.7 µm2; range, 47.7-70.3; P < 0.001); nerve tortuosity (0.08; range, 0.05-0.09) compared with normal eyes (0.04; range, 0.02-0.04; P < 0.001); and keratocyte reflectivity. BC density and CNF length values were found to be significantly less than those for normal controls (both P < 0.001). In all subgroups, CNF length appeared to be significantly lower than that of controls (all P < 0.001), and DC density was only statistically significantly higher in the UK (P = 0.003) and RK (P < 0.001) groups. Corneal fluorescein staining had no correlation with the analyzed IVCM parameters (all P ˃ 0.05). However, the increase in DC density and DC size showed negative correlations to CNF length (density: r = -0.325, P < 0.005; size: r = -0.493, P < 0.005), as well as positive correlations to duration and frequency of topical eye drops and DC size (density: r = 0.361, P < 0.05; size: r = 0.581, P < 0.05). A ROC curve showed that CNF length had the strongest predictive power, with the estimated area under the curve being 0.992 ± 0.008. Lower BC density and CNF length, greater DC density and DC size, and greater keratocyte reflectivity were the microstructural characteristics of TK. The role of subbasal nerve, inflammatory response, and limbal stem cells in the progression of TK and the appropriate treatment of different TK stages are future research directions. The evaluation of basal cells, subbasal nerve, and dendritiform cells is helpful to our understanding of the pathological process of TK.

Identifiants

pubmed: 34495329
pii: 2777879
doi: 10.1167/tvst.10.11.11
pmc: PMC8431974
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11

Références

Semin Ophthalmol. 2010 May;25(3):79-83
pubmed: 20590417
Toxicol In Vitro. 2015 Mar;29(2):370-9
pubmed: 25458483
Surv Ophthalmol. 2017 May - Jun;62(3):286-301
pubmed: 27890620
Ophthalmology. 1989 Aug;96(8):1187-93
pubmed: 2797722
Ophthalmic Physiol Opt. 2005 May;25(3):254-60
pubmed: 15854073
J Curr Ophthalmol. 2018 Oct 19;31(1):16-23
pubmed: 30899841
Ocul Surf. 2017 Jan;15(1):15-47
pubmed: 27771327
Exp Eye Res. 2020 Nov;200:108243
pubmed: 32926895
Indian J Ophthalmol. 2021 Apr;69(4):806-811
pubmed: 33727439
J Refract Surg. 2004 Jan-Feb;20(1):62-71
pubmed: 14763473
Lens Eye Toxic Res. 1992;9(3-4):361-75
pubmed: 1301792
Nat Rev Immunol. 2006 Apr;6(4):318-28
pubmed: 16557263
Ocul Surf. 2020 Jan;18(1):158-169
pubmed: 31740391
Adv Ther. 2015 Apr;32(4):356-69
pubmed: 25893514
Am J Ophthalmol. 2015 Oct;160(4):678-84.e4
pubmed: 26149968
Curr Eye Res. 1986 May;5(5):367-72
pubmed: 3720343
Ocul Surf. 2018 Jan;16(1):101-111
pubmed: 28923503
Eur J Ophthalmol. 2009 Nov-Dec;19(6):916-22
pubmed: 19882588
Cornea. 2003 Jul;22(5):468-72
pubmed: 12827054
Eur J Ophthalmol. 2006 Jul-Aug;16(4):582-7
pubmed: 16952098
Curr Opin Ophthalmol. 2004 Dec;15(6):541-8
pubmed: 15523201
Case Rep Ophthalmol. 2010 Jun 11;1(1):20-23
pubmed: 20737055
Curr Opin Ophthalmol. 2019 Nov;30(6):525-531
pubmed: 31567695
Prog Retin Eye Res. 2019 Nov;73:100762
pubmed: 31075321
Cytometry A. 2004 Apr;58(2):167-76
pubmed: 15057970
Cornea. 2011 May;30(5):571-5
pubmed: 21598429
Trans Am Ophthalmol Soc. 1983;81:854-965
pubmed: 6676985
Toxicol Lett. 2020 Feb 1;319:74-84
pubmed: 31707104
Ophthalmic Res. 2019;61(1):51-59
pubmed: 29627838
Eye (Lond). 2017 Jan;31(1):140-147
pubmed: 27740620
Prog Retin Eye Res. 2018 Sep;66:107-131
pubmed: 29698813
Cornea. 2002 Apr;21(3):265-9
pubmed: 11917174
Acta Ophthalmol. 2011 Jun;89(4):388-95
pubmed: 19900202
Int Ophthalmol Clin. 1998 Fall;38(4):15-22
pubmed: 10081722
Invest Ophthalmol Vis Sci. 2013 Sep 24;54(9):6314-25
pubmed: 23963168
Cutan Ocul Toxicol. 2010 Jun;29(2):105-9
pubmed: 20236030
Cornea. 2019 Mar;38(3):364-375
pubmed: 30614902

Auteurs

Leying Wang (L)

Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Yang Zhang (Y)

Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Zhenyu Wei (Z)

Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Kai Cao (K)

Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Guanyu Su (G)

Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Pedram Hamrah (P)

Cornea Service, New England Eye Center, Center for Translational Ocular Immunology, Department of Ophthalmology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA.

Antoine Labbe (A)

Quinze-Vingts National Ophthalmology Hospital, IHU FOReSIGHT, Paris and Versailles Saint-Quentin-en-Yvelines University, Versailles, France.
Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.

Qingfeng Liang (Q)

Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH